ARTICLE | Company News
Athena Diagnostics, Bionomics sales and marketing update
October 4, 2004 7:00 AM UTC
BNO granted Athena a license to market BNO's Severe Myoclonic Epilepsy of Infancy (SMEI) test for children in North America and Japan. Athena will pay BNO upfront fees, sales-related milestones and ro...